BeiGene

Website: BeiGene
Description: 

A biopharmaceutical company dedicated to becoming a leader in the discovery and development of innovative, molecularly targeted and immuno-oncology drugs for the treatment of cancer.

COVID-19: Testing its BTK inhibitor, Brukinsa, against the disease. 

Location(s): 
Cambridge MA
United States
Fort Lee NJ
United States
Beijing
China